Medical Xpress August 9, 2024
Dr. Sabine Mai, Canada Research Chair in Genomic Instability and Nuclear Architecture of Cancer with the Rady Faculty of Health Sciences recently co-authored an article published in the American Journal of Hematology. The groundbreaking study shows early risk stratification of smoldering multiple myeloma, a precursor state to multiple myeloma, a deadly form of blood cancer.
Multiple myeloma remains an incurable blood cancer, with about 4,000 people newly diagnosed in Canada per year. Patients currently survive an average of eight years after diagnosis.
Patients with smoldering multiple myeloma remain asymptomatic until the disease progresses to multiple myeloma. Currently there is no accurate prognostic tool in the clinic to identify patients who will progress to multiple myeloma.
“Without a cure, the question...